Oncovin Liquid, sol inj 1 mg/ml i.v. , flac 1 ml

7680453230136 CH-45323 L01CA02
Oncovin Liquid, sol inj 1 mg/ml i.v. , flac 1 ml
Oncovin Liquid, sol inj 1 mg/ml i.v. , flac 1 ml
Oncovin Liquid, sol inj 1 mg/ml i.v. , flac 1 ml
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
vincristini sulfas
1.0 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK
propylis parahydroxybenzoas
0.2 MG Substance HBESI
E 218
1.3 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii acetas
- Substance HNIDK
natrium
0.007 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
45323
Drug name
Oncovin Liquid, Injektionslösung
Galenic form
LSINJ
ATC Code
L01CA02
Authorization status
Revoked/Withdrawn
Dispensation category
A
First authorization
01/06/1983
Authorization expiration date
28/02/2025
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
ONCOVIN Liquid sol inj 1 mg/ml i.v. flac 1 ml
Description (DE)
ONCOVIN Liquid Inj Lös 1 mg/ml i.v. Durchstf 1 ml
Market withdrawal
28/02/2025
Narcotic (BTM)
No

Available generics

Vincristine Pfizer, Injektionslösung
CHF 80.30
View
Vincristine Pfizer, Injektionslösung
CHF 126.30
View
Vincristin Teva, Injektionslösung
CHF 29.20
View
Vincristin Teva, Injektionslösung
CHF 38.30
View
Buy us a coffee Explore the data